Corporate Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 23-10-2024
- Paid Up Capital ₹ 0.60 M
as on 23-10-2024
- Company Age 16 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 87.20 M
as on 23-10-2024
- Satisfied Charges ₹ 9.00 M
as on 23-10-2024
- Revenue -18.00%
(FY 2023)
- Profit -3.85%
(FY 2023)
- Ebitda -14.66%
(FY 2023)
- Net Worth 18.15%
(FY 2023)
- Total Assets 25.26%
(FY 2023)
About Corporate Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹8.72 Cr. The company has closed loans amounting to ₹9.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ravinder Sethi and Sudhir Sharma serve as directors at the Company.
- CIN/LLPIN
U24100DL2007PTC172076
- Company No.
172076
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Dec 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Corporate Diagnostics Private Limited offer?
Corporate Diagnostics Private Limited offers a wide range of products and services, including Spectrophotometer, Medical Laboratory Instruments, Pathology Lab Equipments, Laboratory Bath, Water Baths, IVDs & Analyzers, Glucometer, Accu-Chek Glucometer, Blood Collection Tubes, Hematology Analyzers.
Who are the key members and board of directors at Corporate Diagnostics?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sudhir Sharma | Director | 31-Dec-2007 | Current |
Ravinder Sethi | Director | 31-Dec-2007 | Current |
Financial Performance and Corporate Structure Insights of Corporate Diagnostics.
Corporate Diagnostics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 18% decrease. The company also saw a slight decrease in profitability, with a 3.85% decrease in profit. The company's net worth Soared by an impressive increase of 18.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Corporate Diagnostics?
In 2023, Corporate Diagnostics had a promoter holding of 99.98% and a public holding of 0.02%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 29 Jun 2024 | ₹7.20 M | Open |
Others Creation Date: 30 Aug 2013 | ₹5.00 Cr | Open |
Standard Chartered Bank Creation Date: 30 Mar 2010 | ₹3.00 Cr | Open |
How Many Employees Work at Corporate Diagnostics?
Corporate Diagnostics has a workforce of 9 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Corporate Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Corporate Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.